European Commission seeks feedback on revised drug GMPs
This article was originally published in SRA
Executive Summary
The European Commission has launched for public consultation several revisions to the EU guidelines on good manufacturing practices (GMPs) for medicines that include changes relating to supply chain traceability, quality defects/complaints investigations and preventing cross-contamination1.